Heart pump and monitoring for shock after heart attack
Part of Heart & circulation clinical trials.
This trial tests whether using a temporary heart pump plus close monitoring improves recovery in people with severe heart failure after a heart attack, compared to standard care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having a heart attack and your heart is not pumping strongly enough (cardiogenic shock).
- You are planned to have immediate treatment to unblock your artery (angiography and revascularization).
- Your blood pressure is low (below 100) or you need medication to keep it above 90.
- A blood test shows high lactate (above 2.0), which means your body isn't getting enough oxygen.
- An ultrasound of your heart shows weak pumping (ejection fraction below 40%) or another sign of poor blood flow.
- You must be 18 to 80 years old, and your shock must have started within the last 12 hours.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new heart pump (Impella device) for people who have a severe heart attack and go into shock (very low blood pressure). It aims to see if the pump can help the heart recover better than standard care.
This trial is testing a temporary heart pump device that helps your heart pump blood when it's too weak to do its job. It's for people who have severe heart failure (cardiogenic shock) despite getting powerful medications to keep their heart working.
This trial studies whether putting in a small heart pump early (through the leg) helps people with a heart attack complicated by severe heart weakness (“cardiogenic shock”) compared with standard treatment. It aims to improve survival and recovery by supporting blood flow sooner.
This trial tests if unloading the heart during ECMO support helps patients recover better from cardiogenic shock. It compares different ways to reduce the heart's workload.
This trial tests if a temporary heart pump (IABP) can help patients who have had a heart attack and developed a hole in the wall between their heart chambers. Patients must be in an early, less severe stage of shock.
This trial tests a treatment plan for people having a severe heart attack that causes cardiogenic shock, where the heart can't pump enough blood. The study uses a special heart pump to support patients during an emergency procedure to open blocked arteries.
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.